Skip To Content

Study ID: Allergan CMO-US-URO-0470 Overactive Bladder Study

Title:

A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate an Alternative Injection Paradigm for OnabotulinumtoxinA (Botox)in the Treatment of Overactive Bladder in Patients with Urinary Incontinence.

Location:
Sioux Falls Region
Principal Investigator:
Kevin Benson, MD
Disease:
Bladder
Stage:
Phase IV
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.